Date: 2013-10-03 14:58:53

Neuroendocrinology

Peptide hormones

Growth hormones

Growth hormone treatment

Pediatrics

Growth hormone

Lipodystrophy

HIV-associated lipodystrophy

Pituitary adenoma

Endocrine system

Biology

Medicine

PRIOR AUTHORIZATION POLICY Egrifta™ (tesamorelin injection – EMD Serono) To initiate a Coverage Review, Call[removed]OVERVIEW Egrifta is an analog of human growth hormone-releasing factor (GRF), indicated for

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 75,36 KB